Cardiology Research Review, Issue 164, with commentary by A/Prof John Amerena

In this edition:

–  A culturally informed model of care for Indigenous patients with ACS
–  Lipoprotein(a) levels and cardiovascular risk reduction with icosapent ethyl
–  Exercise therapy for chronic symptomatic peripheral artery disease
–  Uniform or sex-specific cardiac troponin thresholds to rule out MI?
–  Extended clopidogrel monotherapy vs DAPT in high-risk patients with ACS
–  Beta-blocker use post-MI in patients with preserved ejection fraction
–  Antihypertensive drug therapy and risk of dementia in the elderly
–  Effects of statin therapy on new-onset diabetes and worsening glycaemia
–  Efficacy and safety of dapagliflozin in patients with acute HF
–  Preventive PCI for vulnerable atherosclerotic coronary plaques

Download the Cardiology Research Review, Issue 164, with commentary by A/Prof John Amerena.(pdf)